Hemophilia Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030
CHAPTER 1. Industry Overview of Hemophilia Market
1.1. Definition and Scope
1.1.1. Definition of Hemophilia
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Hemophilia Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Hemophilia Market By Type
1.2.3. Hemophilia Market By Treatment
1.2.4. Hemophilia Market By Therapy
1.2.5. Hemophilia Market By End-Use
1.2.6. Hemophilia Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Hemophilia Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Hemophilia Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Hemophilia Market By Type
4.1. Introduction
4.2. Hemophilia Market Revenue By Type
4.2.1. Hemophilia Market Revenue (USD Billion) and Forecast, By Type, 2018-2030
4.2.2. Hemophilia A
4.2.2.1. Hemophilia A Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3. Hemophilia B
4.2.3.1. Hemophilia B Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.4. Hemophilia C
4.2.4.1. Hemophilia C Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 5. Hemophilia Market By Treatment
5.1. Introduction
5.2. Hemophilia Market Revenue By Treatment
5.2.1. Hemophilia Market Revenue (USD Billion) and Forecast, By Treatment, 2018-2030
5.2.2. On-Demand
5.2.2.1. On-Demand Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Prophylaxis
5.2.3.1. Prophylaxis Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. Hemophilia Market By Therapy
6.1. Introduction
6.2. Hemophilia Market Revenue By Therapy
6.2.1. Hemophilia Market Revenue (USD Billion) and Forecast, By Therapy, 2018-2030
6.2.2. Replacement Therapy
6.2.2.1. Replacement Therapy Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. Gene Therapy
6.2.3.1. Gene Therapy Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. Hemophilia Market By End-Use
7.1. Introduction
7.2. Hemophilia Market Revenue By End-Use
7.2.1. Hemophilia Market Revenue (USD Billion) and Forecast, By End-Use, 2018-2030
7.2.2. Hospitals
7.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.3. Clinics
7.2.3.1. Clinics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.4. Hemophilia Treatment Centers
7.2.4.1. Hemophilia Treatment Centers Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.5. Others
7.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 8. North America Hemophilia Market By Country
8.1. North America Hemophilia Market Overview
8.2. U.S.
8.2.1. U.S. Hemophilia Market Revenue (USD Billion) and Forecast By Type, 2018-2030
8.2.2. U.S. Hemophilia Market Revenue (USD Billion) and Forecast By Treatment, 2018-2030
8.2.3. U.S. Hemophilia Market Revenue (USD Billion) and Forecast By Therapy, 2018-2030
8.2.4. U.S. Hemophilia Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.3. Canada
8.3.1. Canada Hemophilia Market Revenue (USD Billion) and Forecast By Type, 2018-2030
8.3.2. Canada Hemophilia Market Revenue (USD Billion) and Forecast By Treatment, 2018-2030
8.3.3. Canada Hemophilia Market Revenue (USD Billion) and Forecast By Therapy, 2018-2030
8.3.4. Canada Hemophilia Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
8.4. North America PEST Analysis
CHAPTER 9. Europe Hemophilia Market By Country
9.1. Europe Hemophilia Market Overview
9.2. U.K.
9.2.1. U.K. Hemophilia Market Revenue (USD Billion) and Forecast By Type, 2018-2030
9.2.2. U.K. Hemophilia Market Revenue (USD Billion) and Forecast By Treatment, 2018-2030
9.2.3. U.K. Hemophilia Market Revenue (USD Billion) and Forecast By Therapy, 2018-2030
9.2.4. U.K. Hemophilia Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.3. Germany
9.3.1. Germany Hemophilia Market Revenue (USD Billion) and Forecast By Type, 2018-2030
9.3.2. Germany Hemophilia Market Revenue (USD Billion) and Forecast By Treatment, 2018-2030
9.3.3. Germany Hemophilia Market Revenue (USD Billion) and Forecast By Therapy, 2018-2030
9.3.4. Germany Hemophilia Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.4. France
9.4.1. France Hemophilia Market Revenue (USD Billion) and Forecast By Type, 2018-2030
9.4.2. France Hemophilia Market Revenue (USD Billion) and Forecast By Treatment, 2018-2030
9.4.3. France Hemophilia Market Revenue (USD Billion) and Forecast By Therapy, 2018-2030
9.4.4. France Hemophilia Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.5. Spain
9.5.1. Spain Hemophilia Market Revenue (USD Billion) and Forecast By Type, 2018-2030
9.5.2. Spain Hemophilia Market Revenue (USD Billion) and Forecast By Treatment, 2018-2030
9.5.3. Spain Hemophilia Market Revenue (USD Billion) and Forecast By Therapy, 2018-2030
9.5.4. Spain Hemophilia Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.6. Rest of Europe
9.6.1. Rest of Europe Hemophilia Market Revenue (USD Billion) and Forecast By Type, 2018-2030
9.6.2. Rest of Europe Hemophilia Market Revenue (USD Billion) and Forecast By Treatment, 2018-2030
9.6.3. Rest of Europe Hemophilia Market Revenue (USD Billion) and Forecast By Therapy, 2018-2030
9.6.4. Rest of Europe Hemophilia Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.7. Europe PEST Analysis
CHAPTER 10. Asia-Pacific Hemophilia Market By Country
10.1. Asia-Pacific Hemophilia Market Overview
10.2. China
10.2.1. China Hemophilia Market Revenue (USD Billion) and Forecast By Type, 2018-2030
10.2.2. China Hemophilia Market Revenue (USD Billion) and Forecast By Treatment, 2018-2030
10.2.3. China Hemophilia Market Revenue (USD Billion) and Forecast By Therapy, 2018-2030
10.2.4. China Hemophilia Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.3. Japan
10.3.1. Japan Hemophilia Market Revenue (USD Billion) and Forecast By Type, 2018-2030
10.3.2. Japan Hemophilia Market Revenue (USD Billion) and Forecast By Treatment, 2018-2030
10.3.3. Japan Hemophilia Market Revenue (USD Billion) and Forecast By Therapy, 2018-2030
10.3.4. Japan Hemophilia Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.4. India
10.4.1. India Hemophilia Market Revenue (USD Billion) and Forecast By Type, 2018-2030
10.4.2. India Hemophilia Market Revenue (USD Billion) and Forecast By Treatment, 2018-2030
10.4.3. India Hemophilia Market Revenue (USD Billion) and Forecast By Therapy, 2018-2030
10.4.4. India Hemophilia Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.5. Australia
10.5.1. Australia Hemophilia Market Revenue (USD Billion) and Forecast By Type, 2018-2030
10.5.2. Australia Hemophilia Market Revenue (USD Billion) and Forecast By Treatment, 2018-2030
10.5.3. Australia Hemophilia Market Revenue (USD Billion) and Forecast By Therapy, 2018-2030
10.5.4. Australia Hemophilia Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.6. South Korea
10.6.1. South Korea Hemophilia Market Revenue (USD Billion) and Forecast By Type, 2018-2030
10.6.2. South Korea Hemophilia Market Revenue (USD Billion) and Forecast By Treatment, 2018-2030
10.6.3. South Korea Hemophilia Market Revenue (USD Billion) and Forecast By Therapy, 2018-2030
10.6.4. South Korea Hemophilia Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Hemophilia Market Revenue (USD Billion) and Forecast By Type, 2018-2030
10.7.2. Rest of Asia-Pacific Hemophilia Market Revenue (USD Billion) and Forecast By Treatment, 2018-2030
10.7.3. Rest of Asia-Pacific Hemophilia Market Revenue (USD Billion) and Forecast By Therapy, 2018-2030
10.7.4. Rest of Asia-Pacific Hemophilia Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.8. Asia-Pacific PEST Analysis
CHAPTER 11. Latin America Hemophilia Market By Country
11.1. Latin America Hemophilia Market Overview
11.2. Brazil
11.2.1. Brazil Hemophilia Market Revenue (USD Billion) and Forecast By Type, 2018-2030
11.2.2. Brazil Hemophilia Market Revenue (USD Billion) and Forecast By Treatment, 2018-2030
11.2.3. Brazil Hemophilia Market Revenue (USD Billion) and Forecast By Therapy, 2018-2030
11.2.4. Brazil Hemophilia Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.3. Mexico
11.3.1. Mexico Hemophilia Market Revenue (USD Billion) and Forecast By Type, 2018-2030
11.3.2. Mexico Hemophilia Market Revenue (USD Billion) and Forecast By Treatment, 2018-2030
11.3.3. Mexico Hemophilia Market Revenue (USD Billion) and Forecast By Therapy, 2018-2030
11.3.4. Mexico Hemophilia Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.4. Rest of Latin America
11.4.1. Rest of Latin America Hemophilia Market Revenue (USD Billion) and Forecast By Type, 2018-2030
11.4.2. Rest of Latin America Hemophilia Market Revenue (USD Billion) and Forecast By Treatment, 2018-2030
11.4.3. Rest of Latin America Hemophilia Market Revenue (USD Billion) and Forecast By Therapy, 2018-2030
11.4.4. Rest of Latin America Hemophilia Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Hemophilia Market By Country
12.1. Middle East & Africa Hemophilia Market Overview
12.2. GCC
12.2.1. GCC Hemophilia Market Revenue (USD Billion) and Forecast By Type, 2018-2030
12.2.2. GCC Hemophilia Market Revenue (USD Billion) and Forecast By Treatment, 2018-2030
12.2.3. GCC Hemophilia Market Revenue (USD Billion) and Forecast By Therapy, 2018-2030
12.2.4. GCC Hemophilia Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.3. South Africa
12.3.1. South Africa Hemophilia Market Revenue (USD Billion) and Forecast By Type, 2018-2030
12.3.2. South Africa Hemophilia Market Revenue (USD Billion) and Forecast By Treatment, 2018-2030
12.3.3. South Africa Hemophilia Market Revenue (USD Billion) and Forecast By Therapy, 2018-2030
12.3.4. South Africa Hemophilia Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Hemophilia Market Revenue (USD Billion) and Forecast By Type, 2018-2030
12.4.2. Rest of Middle East & Africa Hemophilia Market Revenue (USD Billion) and Forecast By Treatment, 2018-2030
12.4.3. Rest of Middle East & Africa Hemophilia Market Revenue (USD Billion) and Forecast By Therapy, 2018-2030
12.4.4. Rest of Middle East & Africa Hemophilia Market Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Hemophilia Market
13.1. Hemophilia Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Hemophilia Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Baxalta
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Billion), 2021
14.1.3.2. Baxalta 2021 Hemophilia Business Regional Distribution
14.1.4. Product /Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. SL Behring
14.3. Pfizer, Inc.
14.4. Bayer Healthcare
14.5. BioMarin Pharmaceutical, Inc.
14.6. Biogen
14.7. Chugai Pharmaceutical Co.
14.8. Novo Nordisk
14.9. Shire Plc
Frequently Asked Questions
What is the size of global hemophilia market in 2021?
The market size of hemophilia market in 2021 was accounted to be USD 12.2 Billion.
What is the CAGR of global hemophilia market during forecast period of 2022 to 2030?
The projected CAGR of hemophilia market during the analysis period of 2022 to 2030 is 6.9%.
Which are the key players operating in the market?
The prominent players of the global hemophilia market include Baxalta, CSL Behring, Pfizer, Inc., Bayer Healthcare, BioMarin Pharmaceutical, Inc., Biogen, Chugai Pharmaceutical Co., Novo Nordisk, and Shire Plc.
Which region held the dominating position in the global hemophilia market?
North America held the dominating hemophilia during the analysis period of 2022 to 2030.
Which region registered the fastest growing CAGR for the forecast period of 2022 to 2030?
Asia-Pacific region exhibited fastest growing CAGR for hemophilia during the analysis period of 2022 to 2030.
What are the current trends and dynamics in the global hemophilia market?
Increasing prevalence of hemophilia in the world, growing incidences of hemophilia in new-borns, growth in hemophilia inhibitors, and surging trend of prophylaxis treatment drives the growth of global hemophilia market.
Which Type held the maximum share in 2021?
Based on type, hemophilia A segment is expected to hold the maximum share of the hemophilia market.
Select Licence Type
Connect with our sales team
Why Acumen Research and Consulting
100%
Customer Satisfaction
24x7+
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
